Imiquimod-side effects in the treatment of periocular skin cancers: A review of the literature

Dermatol Ther. 2022 Apr;35(4):e15326. doi: 10.1111/dth.15326. Epub 2022 Jan 31.

Authors

Gianluca Avallone¹, Martina Merli¹, Carmen Dell'Aquila², Pietro Quaglino¹, Simone Ribero¹, Iris Zalaudek³, Claudio Conforti³

Affiliations

¹ Department of Medical Sciences University of Turin, Dermatology Clinic, Turin, Italy.
² Department of Medical, Surgical Sciences and Health, Eye Clinic, University of Trieste, Trieste, Italy.
³ Dermatology Clinic, Maggiore Hospital of Trieste, Trieste, Italy.

PMID: 35064999
DOI: 10.1111/dth.15326

No abstract available

Publication types

Letter
Review

MeSH terms

Aminoquinolines / adverse effects
Antineoplastic Agents* / adverse effects
Carcinoma, Basal Cell* / chemically induced
Carcinoma, Basal Cell* / drug therapy
Humans
Imiquimod / adverse effects
Skin Neoplasms* / chemically induced
Skin Neoplasms* / drug therapy

Substances

Aminoquinolines
Antineoplastic Agents
Imiquimod